标题
An update on the use of rifapentine for tuberculosis therapy
作者
关键词
-
出版物
Expert Opinion on Drug Delivery
Volume 11, Issue 3, Pages 421-431
出版商
Informa Healthcare
发表日期
2014-01-08
DOI
10.1517/17425247.2014.877886
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sutezolid. Oxazolidinone antibacterial, treatment of tuberculosis
- (2014) J.-P. Lanoix et al. DRUGS OF THE FUTURE
- Phase I, Single-Dose, Dose-Escalating Study of Inhaled Dry Powder Capreomycin: a New Approach to Therapy of Drug-Resistant Tuberculosis
- (2013) Ashwin S. Dharmadhikari et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contradictory Results with High-Dosage Rifamycin in Mice and Humans
- (2013) A. R. M. Coates et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Reply to "Contradictory Results with High-Dosage Rifamycin in Mice and Humans"
- (2013) E. L. Nuermberger et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Preliminary Pharmacokinetic Study of Repeated Doses of Rifampin and Rifapentine in Guinea Pigs
- (2013) Noton K. Dutta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of repeated dosing on rifampin exposure in BALB/c mice
- (2013) Vinayak Hosagrahara et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Dry Powder Antibiotic Aerosol Product Development: Inhaled Therapy for Tuberculosis
- (2013) Anthony J. Hickey et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Rifapentine Is Not More Active than Rifampin against Chronic Tuberculosis in Guinea Pigs
- (2012) Noton K. Dutta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dose-Ranging Comparison of Rifampin and Rifapentine in Two Pathologically Distinct Murine Models of Tuberculosis
- (2012) Ian M. Rosenthal et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety and Pharmacokinetics of Escalating Daily Doses of the Antituberculosis Drug Rifapentine in Healthy Volunteers
- (2012) K E Dooley et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Preparation and characterization of rifampicin-PLGA microspheres/sodium alginate in situ gel combination delivery system
- (2012) Chunhui Hu et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Formulation and in vitro characterization of inhalable polyvinyl alcohol-free rifampicin-loaded PLGA microspheres prepared with sucrose palmitate as stabilizer: Efficiency for ex vivo alveolar macrophage targeting
- (2012) R. Diab et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Pharmacokinetic/pharmacodynamic parameters and the choice of high-dosage rifamycins
- (2012) D. A. Mitchison INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium
- (2012) S. E. Dorman et al. JOURNAL OF INFECTIOUS DISEASES
- Preparation of sustained release rifampicin microparticles for inhalation
- (2012) Yoen-Ju Son et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
- (2012) Andreas H Diacon et al. LANCET
- Partial Biodistribution and Pharmacokinetics of Isoniazid and Rifabutin Following Pulmonary Delivery of Inhalable Microparticles to Rhesus Macaques
- (2012) Rahul Kumar Verma et al. MOLECULAR PHARMACEUTICS
- Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
- (2012) Maria Tarcela Gler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preparation of rifampicin/lactose microparticle composites by a supercritical antisolvent-drug excipient mixing technique for inhalation delivery
- (2012) Courtney A. Ober et al. POWDER TECHNOLOGY
- Treatment of Tuberculosis with Rifamycin-containing Regimens in Immune-deficient Mice
- (2011) Ming Zhang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Short-Course Chemotherapy with TMC207 and Rifapentine in a Murine Model of Latent Tuberculosis Infection
- (2011) Tianyu Zhang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
- (2011) J. van Ingen et al. CLINICAL INFECTIOUS DISEASES
- A new respirable form of rifampicin
- (2011) Yoen-Ju Son et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery
- (2011) T.V.P. Doan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Mouse Model of Necrotic Tuberculosis Granulomas Develops Hypoxic Lesions
- (2011) Jamie Harper et al. JOURNAL OF INFECTIOUS DISEASES
- Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
- (2011) Timothy R. Sterling et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential Economic Viability of Two Proposed Rifapentine-Based Regimens for Treatment of Latent Tuberculosis Infection
- (2011) David P. Holland et al. PLoS One
- Effects of Four Different Meal Types on the Population Pharmacokinetics of Single-Dose Rifapentine in Healthy Male Volunteers
- (2010) S. P. Zvada et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dry Powder PA-824 Aerosols for Treatment of Tuberculosis in Guinea Pigs
- (2010) L. Garcia-Contreras et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig
- (2010) Z. Ahmad et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Rifamycins – Obstacles and opportunities
- (2010) Paul A. Aristoff et al. TUBERCULOSIS
- Inhaled drug therapy for treatment of tuberculosis
- (2010) Amit Misra et al. TUBERCULOSIS
- Inhalable microparticles modify cytokine secretion by lung macrophages of infected mice
- (2010) Rolee Sharma et al. TUBERCULOSIS
- Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis
- (2009) Susan E. Dorman et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Short-Course Therapy with Daily Rifapentine in a Murine Model of Latent Tuberculosis Infection
- (2009) Tianyu Zhang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Costs and Cost-effectiveness of Four Treatment Regimens for Latent Tuberculosis Infection
- (2009) David P. Holland et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Dry Powder Nitroimidazopyran Antibiotic PA-824 Aerosol for Inhalation
- (2009) J. C. Sung et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of SQ641, a Capuramycin Analog, in a Murine Model of Tuberculosis
- (2009) B. V. Nikonenko et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- 4 Months of Rifampin Compared with 9 Months of Isoniazid for the Management of Latent Tuberculosis Infection: A Meta‐analysis and Cost‐Effectiveness Study That Focuses on Compliance and Liver Toxicity
- (2009) Panayiotis D. Ziakas et al. CLINICAL INFECTIOUS DISEASES
- Delivery of rifampicin–PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis
- (2009) Keiji Hirota et al. JOURNAL OF CONTROLLED RELEASE
- Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting
- (2009) Navneet Nimje et al. JOURNAL OF DRUG TARGETING
- Biphasic Kill Curve of Isoniazid Reveals the Presence of Drug‐Tolerant, Not Drug‐Resistant,Mycobacterium tuberculosisin the Guinea Pig
- (2009) Zahoor Ahmad et al. JOURNAL OF INFECTIOUS DISEASES
- Non-invasive Systemic Drug Delivery: Developability Considerations for Alternate Routes of Administration
- (2009) Neil R. Mathias et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Formulation and Pharmacokinetics of Self-Assembled Rifampicin Nanoparticle Systems for Pulmonary Delivery
- (2009) Jean C. Sung et al. PHARMACEUTICAL RESEARCH
- Slow Release Formulations of Inhaled Rifampin
- (2008) Intira Coowanitwong et al. AAPS Journal
- Application of a Four-fluid Nozzle Spray Drier to Prepare Inhalable Rifampicin-containing Mannitol Microparticles
- (2008) Takuto Mizoe et al. AAPS PHARMSCITECH
- Repeated Administration of High-Dose Intermittent Rifapentine Reduces Rifapentine and Moxifloxacin Plasma Concentrations
- (2008) K. Dooley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intracellular Time Course, Pharmacokinetics, and Biodistribution of Isoniazid and Rifabutin following Pulmonary Delivery of Inhalable Microparticles to Mice
- (2008) R. K. Verma et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
- (2008) R. Singh et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started